现代医药卫生
現代醫藥衛生
현대의약위생
MODERN MEDICINE HEALTH
2015年
12期
1767-1769
,共3页
王鑫%乔海%张瑞涛%吴庆蓉%陈锦云
王鑫%喬海%張瑞濤%吳慶蓉%陳錦雲
왕흠%교해%장서도%오경용%진금운
子宫内膜异位症%超声,高强聚焦,经肠%左炔诺孕酮%P物质
子宮內膜異位癥%超聲,高彊聚焦,經腸%左炔諾孕酮%P物質
자궁내막이위증%초성,고강취초,경장%좌결낙잉동%P물질
Endometriosis%Ultrasound,high-Intensity focused,transrectal%Levonorgestrel%Substance P
目的:探讨高强度聚焦超声(HIFU)联合左炔诺孕酮宫内缓释系统(LNG-IUS)治疗子宫腺肌病的临床疗效及安全性。方法选择2014年3~7月在重庆市涪陵中心医院确诊为子宫腺肌病患者40例,随机分为HIFU组和HIFU联合LNG-IUS组,各20例。治疗前和治疗后2、3、6个月进行视觉模拟评分(VAS),并检测血浆P物质水平;测量治疗后3、6个月子宫体积。结果两组患者治疗后2、3、6个月VAS及血浆P物质水平较治疗前显著降低,HIFU联合LNG-IUS组降低程度优于HIFU组,差异均有统计学意义(P<0.05)。治疗后3、6个月,两组患者子宫体积较治疗前显著缩小,差异均有统计学意义(P<0.05);但两组治疗后子宫体积比较,差异无统计学意义(P>0.05)。所有患者在整个HIFU治疗及放置LNG-IUS过程中无严重不良反应发生。结论 HIFU联合LNG-IUS治疗子宫腺肌病较单纯HIFU疗效显著,是一种安全、有效的方法。
目的:探討高彊度聚焦超聲(HIFU)聯閤左炔諾孕酮宮內緩釋繫統(LNG-IUS)治療子宮腺肌病的臨床療效及安全性。方法選擇2014年3~7月在重慶市涪陵中心醫院確診為子宮腺肌病患者40例,隨機分為HIFU組和HIFU聯閤LNG-IUS組,各20例。治療前和治療後2、3、6箇月進行視覺模擬評分(VAS),併檢測血漿P物質水平;測量治療後3、6箇月子宮體積。結果兩組患者治療後2、3、6箇月VAS及血漿P物質水平較治療前顯著降低,HIFU聯閤LNG-IUS組降低程度優于HIFU組,差異均有統計學意義(P<0.05)。治療後3、6箇月,兩組患者子宮體積較治療前顯著縮小,差異均有統計學意義(P<0.05);但兩組治療後子宮體積比較,差異無統計學意義(P>0.05)。所有患者在整箇HIFU治療及放置LNG-IUS過程中無嚴重不良反應髮生。結論 HIFU聯閤LNG-IUS治療子宮腺肌病較單純HIFU療效顯著,是一種安全、有效的方法。
목적:탐토고강도취초초성(HIFU)연합좌결낙잉동궁내완석계통(LNG-IUS)치료자궁선기병적림상료효급안전성。방법선택2014년3~7월재중경시부릉중심의원학진위자궁선기병환자40례,수궤분위HIFU조화HIFU연합LNG-IUS조,각20례。치료전화치료후2、3、6개월진행시각모의평분(VAS),병검측혈장P물질수평;측량치료후3、6개월자궁체적。결과량조환자치료후2、3、6개월VAS급혈장P물질수평교치료전현저강저,HIFU연합LNG-IUS조강저정도우우HIFU조,차이균유통계학의의(P<0.05)。치료후3、6개월,량조환자자궁체적교치료전현저축소,차이균유통계학의의(P<0.05);단량조치료후자궁체적비교,차이무통계학의의(P>0.05)。소유환자재정개HIFU치료급방치LNG-IUS과정중무엄중불량반응발생。결론 HIFU연합LNG-IUS치료자궁선기병교단순HIFU료효현저,시일충안전、유효적방법。
Objective To investigate the clinical curative effect and safety of high intensity focused ultrasound (HIFU) for treating adenomyosis combined with levonorgestrel-releasing intrauterine system(LNG-IUS). Methods 40 patients diagnosed as adenomyosis in Chongqing Fuling Central Hospital from March 2014 to July 2014 were selected and randomly divided into the HIFU group(n=20) and HIFU combined LNG-IUS group(n=20). The visual analogue scale(VAS) was conducted before and af-ter 2,3,6 months of treatment and plasma levels of substance P was detected . The uterus size after 3 ,6 months of treatment was measured. Results The VAS score and plasma levels of substance P of both groups were remarkably reduced after 2 ,3,6 months of treatment. However,the VAS score and plasma levels of substance P of the HIFU combined LNG-IUS group were reduced more than those of the HIFU group,differences showing statistical significance(P<0.05). The uterus sizes of both groups shrank notably after 3,6 months of treatment,differences showing statistical significance(P<0.05). The uterus sizes after treatment had no statis-tical differences between the two groups(P>0.05). All the patients had no severe adverse reactions during entire HIFU treatment and LNG-IUS placing process. Conclusion HIFU combined with LNG-IUS has significant effect for treating adenomyosis and is a safe and effective method.